Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients
Authors:
- Sang Soo KimSKSang Soo Kim
- In Joo KimIKIn Joo Kim
- Sang Heon SongSSSang Heon Song
- Yong Ki KimYKYong Ki Kim
- Ju In KimJKJu In Kim
- Yun Kyung JeonYJYun Kyung Jeon
- Bo Hyun KimBKBo Hyun Kim
- Ihm Soo KwakIKIhm Soo Kwak
- 1 July 2012
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 26 (4) , 308-312
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- YKL-40 levels are independently associated with albuminuria in type 2 diabetesCardiovascular Diabetology, 2011
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathyNature Reviews Nephrology, 2011
- YKL‐40 in type 2 diabetic patients with different levels of albuminuriaEuropean Journal of Clinical Investigation, 2010
- Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery diseaseAtherosclerosis, 2010
- Urinary biomarkers involved in type 2 diabetes: a reviewDiabetes/Metabolism Research and Reviews, 2010
- YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of AlbuminuriaDiabetes Care, 2009
- Plasma YKL-40Diabetes, 2008
- Serum YKL-40 levels in patients with coronary artery diseaseCoronary Artery Disease, 2007
- C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?Hypertension, 2004
- YKL‐40, a Matrix Protein of Specific Granules in Neutrophils, Is Elevated in Serum of Patients with Community‐Acquired Pneumonia Requiring HospitalizationThe Journal of Infectious Diseases, 1999